Zhang L - Search Results

1

Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study.

Zheng L, Zhou ZR, Shi M, Chen H, Yu QQ, Yang Y, Liu L, Zhang L, Guo Y, Zhou X, Li C, Wei Q. Zheng L, et al. Among authors: zhang l. Ann Transl Med. 2021 Apr;9(7):571. doi: 10.21037/atm-21-673. Ann Transl Med. 2021. PMID: 33987269 Free PMC article.

2

Glioma SOX2 expression decreased after adjuvant therapy.

Yu W, Ren X, Hu C, Tan Y, Shui Y, Chen Z, Zhang L, Peng J, Wei Q. Yu W, et al. Among authors: zhang l. BMC Cancer. 2019 Nov 12;19(1):1087. doi: 10.1186/s12885-019-6292-y. BMC Cancer. 2019. PMID: 31718604 Free PMC article.

3

Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.

Yu W, Hu C, Shui Y, Wu K, Zhang L, Chen Y, Li C, Xu J, Wei Q. Yu W, et al. Among authors: zhang l. BMC Cancer. 2019 Nov 14;19(1):1108. doi: 10.1186/s12885-019-6328-3. BMC Cancer. 2019. PMID: 31727017 Free PMC article.

4

O⁶-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy.

Yu W, Zhang L, Wei Q, Shao A. Yu W, et al. Among authors: zhang l. Front Oncol. 2020 Jan 17;9:1547. doi: 10.3389/fonc.2019.01547. eCollection 2019. Front Oncol. 2020. PMID: 32010632 Free PMC article. Review.

5

Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma.

Liu L, Shui Y, Yu Q, Guo Y, Zhang L, Zhou X, Yu R, Lou J, Wei S, Wei Q. Liu L, et al. Among authors: zhang l. Front Oncol. 2021 Jan 21;10:610636. doi: 10.3389/fonc.2020.610636. eCollection 2020. Front Oncol. 2021. PMID: 33552983 Free PMC article.

6

Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients.

Qian Y, Lou K, Zhou H, Zhang L, Yuan Y. Qian Y, et al. Among authors: zhang l. Front Oncol. 2022 Dec 9;12:1042451. doi: 10.3389/fonc.2022.1042451. eCollection 2022. Front Oncol. 2022. PMID: 36568219 Free PMC article.

7

Utilization of invariant natural killer T cells for gastric cancer treatment.

Xu Q, Li J, Zhang N, Zhang L, Qian R. Xu Q, et al. Among authors: zhang n, zhang l. Future Oncol. 2018 Aug;14(20):2053-2066. doi: 10.2217/fon-2017-0724. Epub 2018 Jul 27. Future Oncol. 2018. PMID: 30051730

8

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.

Cao J, Teng Y, Li H, Zhang L, Ouyang Q, Xie W, Pan Y, Song Z, Ling X, Wu X, Xu J, Li L, Ren L, Wang H, Zhou D, Luo J, Hu X. Cao J, et al. Among authors: zhang l. BMC Med. 2023 Aug 9;21(1):300. doi: 10.1186/s12916-023-02999-0. BMC Med. 2023. PMID: 37559142 Free PMC article. Clinical Trial.

9

Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients.

Xiong W, Xu T, Liu X, Zhang L, Yuan Y. Xiong W, et al. Among authors: zhang l. Cancer. 2024 Apr 15;130(S8):1488-1498. doi: 10.1002/cncr.35206. Epub 2024 Jan 25. Cancer. 2024. PMID: 38271397

10

The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer.

Xu T, Xiong W, Zhang L, Yuan Y. Xu T, et al. Among authors: zhang l. Breast J. 2024 Aug 2;2024:5396107. doi: 10.1155/2024/5396107. eCollection 2024. Breast J. 2024. PMID: 39742382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,313 results

Search Page

Filters